Works matching IS 13889842 AND DT 2022 AND VI 24 AND IP 10

Results: 42
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Renal effects of empagliflozin in patients hospitalized for acute heart failure: from the EMPULSE trial.

    Published in:
    European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1844, doi. 10.1002/ejhf.2681
    By:
    • Voors, Adriaan A.;
    • Damman, Kevin;
    • Teerlink, John R.;
    • Angermann, Christiane E.;
    • Collins, Sean P.;
    • Kosiborod, Mikhail;
    • Biegus, Jan;
    • Ferreira, João Pedro;
    • Nassif, Michael E.;
    • Psotka, Mitchell A.;
    • Tromp, Jasper;
    • Brueckmann, Martina;
    • Blatchford, Jonathan P.;
    • Salsali, Afshin;
    • Ponikowski, Piotr
    Publication type:
    Article
    14
    15
    16

    Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology.

    Published in:
    European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1767, doi. 10.1002/ejhf.2675
    By:
    • Bayes‐Genis, Antoni;
    • Aimo, Alberto;
    • Jhund, Pardeep;
    • Richards, Mark;
    • de Boer, Rudolf A.;
    • Arfsten, Henrike;
    • Fabiani, Iacopo;
    • Lupón, Josep;
    • Anker, Stefan D.;
    • González, Arantxa;
    • Castiglione, Vincenzo;
    • Metra, Marco;
    • Mueller, Christian;
    • Núñez, Julio;
    • Rossignol, Patrick;
    • Barison, Andrea;
    • Butler, Javed;
    • Teerlink, John;
    • Filippatos, Gerasimos;
    • Ponikowski, Piotr
    Publication type:
    Article
    17
    18
    19

    Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial.

    Published in:
    European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1805, doi. 10.1002/ejhf.2670
    By:
    • Branch, Kelley R.H.;
    • Dagenais, Gilles R.;
    • Avezum, Alvaro;
    • Basile, Jan;
    • Conget, Ignacio;
    • Cushman, William C.;
    • Jansky, Petr;
    • Lakshmanan, Mark;
    • Lanas, Fernando;
    • Leiter, Lawrence A.;
    • Pais, Prem;
    • Pogosova, Nana;
    • Raubenheimer, Peter J.;
    • Ryden, Lars;
    • Shaw, Jonathan E.;
    • Sheu, Wayne H.H.;
    • Temelkova‐Kurktschiev, Theodora;
    • Bethel, M. Angelyn;
    • Gerstein, Hertzel C.;
    • Chinthanie, Ramasundarahettige
    Publication type:
    Article
    20
    21

    Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology.

    Published in:
    European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1751, doi. 10.1002/ejhf.2664
    By:
    • Núñez, Julio;
    • de la Espriella, Rafael;
    • Rossignol, Patrick;
    • Voors, Adriaan A.;
    • Mullens, Wilfried;
    • Metra, Marco;
    • Chioncel, Ovidiu;
    • Januzzi, James L.;
    • Mueller, Christian;
    • Richards, A. Mark;
    • de Boer, Rudolf A.;
    • Thum, Thomas;
    • Arfsten, Henrike;
    • González, Arantxa;
    • Abdelhamid, Magdy;
    • Adamopoulos, Stamatis;
    • Anker, Stefan D.;
    • Gal, Tuvia Ben;
    • Biegus, Jan;
    • Cohen‐Solal, Alain
    Publication type:
    Article
    22

    Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win‐ratio analysis of the PARADISE‐MI trial.

    Published in:
    European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1918, doi. 10.1002/ejhf.2663
    By:
    • Berwanger, Otavio;
    • Pfeffer, Marc;
    • Claggett, Brian;
    • Jering, Karola S.;
    • Maggioni, Aldo P.;
    • Steg, Philippe Gabriel;
    • Mehran, Roxana;
    • Lewis, Eldrin F.;
    • Zhou, Yinong;
    • van der Meer, Peter;
    • De Pasquale, Carmine;
    • Merkely, Béla;
    • Filippatos, Gerasimos;
    • McMurray, John J.V.;
    • Granger, Christopher B.;
    • Solomon, Scott D.;
    • Braunwald, Eugene
    Publication type:
    Article
    23
    24
    25
    26

    Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.

    Published in:
    European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1892, doi. 10.1002/ejhf.2652
    By:
    • Ostrominski, John W.;
    • Vaduganathan, Muthiah;
    • Claggett, Brian L.;
    • de Boer, Rudolf A.;
    • Desai, Akshay S.;
    • Dobreanu, Dan;
    • Hernandez, Adrian F.;
    • Inzucchi, Silvio E.;
    • Jhund, Pardeep S.;
    • Kosiborod, Mikhail;
    • Lam, Carolyn S.P.;
    • Langkilde, Anna M.;
    • Lindholm, Daniel;
    • Martinez, Felipe A.;
    • O'Meara, Eileen;
    • Petersson, Magnus;
    • Shah, Sanjiv J.;
    • Thierer, Jorge;
    • McMurray, John J.V.;
    • Solomon, Scott D.
    Publication type:
    Article
    27

    Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA‐HF.

    Published in:
    European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1856, doi. 10.1002/ejhf.2649
    By:
    • Adamson, Carly;
    • Cowan, Lorna M.;
    • de Boer, Rudolf A.;
    • Diez, Mirta;
    • Drożdż, Jarosław;
    • Dukát, Andre;
    • Inzucchi, Silvio E.;
    • Køber, Lars;
    • Kosiborod, Mikhail N.;
    • Ljungman, Charlotta E.A.;
    • Martinez, Felipe A.;
    • Ponikowski, Piotr;
    • Sabatine, Marc S.;
    • Lindholm, Daniel;
    • Bengtsson, Olof;
    • Boulton, David W.;
    • Greasley, Peter J.;
    • Langkilde, Anna Maria;
    • Sjöstrand, Mikaela;
    • Solomon, Scott D.
    Publication type:
    Article
    28
    29
    30
    31

    Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM‐AHF trial.

    Published in:
    European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1928, doi. 10.1002/ejhf.2630
    By:
    • Metra, Marco;
    • Jankowska, Ewa A.;
    • Pagnesi, Matteo;
    • Anker, Stefan D.;
    • Butler, Javed;
    • Dorigotti, Fabio;
    • Fabien, Vincent;
    • Filippatos, Gerasimos;
    • Kirwan, Bridget‐Anne;
    • Macdougall, Iain C.;
    • Rosano, Giuseppe;
    • Ruschitzka, Frank;
    • Tomasoni, Daniela;
    • van der Meer, Peter;
    • Ponikowski, Piotr
    Publication type:
    Article
    32

    Safety and efficacy of istaroxime in patients with acute heart failure‐related pre‐cardiogenic shock – a multicentre, randomized, double‐blind, placebo‐controlled, parallel group study (SEISMiC).

    Published in:
    European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1967, doi. 10.1002/ejhf.2629
    By:
    • Metra, Marco;
    • Chioncel, Ovidiu;
    • Cotter, Gad;
    • Davison, Beth;
    • Filippatos, Gerasimos;
    • Mebazaa, Alexandre;
    • Novosadova, Maria;
    • Ponikowski, Piotr;
    • Simmons, Phillip;
    • Soffer, Joseph;
    • Simonson, Steven
    Publication type:
    Article
    33

    Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure.

    Published in:
    European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1940, doi. 10.1002/ejhf.2628
    By:
    • Caravita, Sergio;
    • Faini, Andrea;
    • Vignati, Carlo;
    • Pelucchi, Sara;
    • Salvioni, Elisabetta;
    • Cattadori, Gaia;
    • Baratto, Claudia;
    • Torlasco, Camilla;
    • Contini, Mauro;
    • Villani, Alessandra;
    • Malfatto, Gabriella;
    • Perger, Elisa;
    • Lombardi, Carolina;
    • Piperno, Alberto;
    • Agostoni, Piergiuseppe;
    • Parati, Gianfranco
    Publication type:
    Article
    34
    35

    Particular challenges in the use of pulmonary vasodilating therapy for patients with pulmonary hypertension secondary to left heart disease. Letter regarding the article ′Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo‐controlled multicentre trial'

    Published in:
    European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1990, doi. 10.1002/ejhf.2622
    By:
    • Dandel, Michael;
    • Hetzer, Roland
    Publication type:
    Article
    36
    37
    38
    39
    40

    Short‐term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA‐VO<sub>2</sub>): a randomized clinical trial.

    Published in:
    European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1816, doi. 10.1002/ejhf.2560
    By:
    • Palau, Patricia;
    • Amiguet, Martina;
    • Domínguez, Eloy;
    • Sastre, Clara;
    • Mollar, Anna;
    • Seller, Julia;
    • Garcia Pinilla, Jose Manuel;
    • Larumbe, Ainoha;
    • Valle, Alfonso;
    • Gómez Doblas, Juan Jose;
    • de la Espriella, Rafael;
    • Miñana, Gema;
    • Mezcua, Ainhoa Robles;
    • Santas, Enrique;
    • Bodí, Vicent;
    • Sanchis, Juan;
    • Pascual‐Figal, Domingo;
    • Górriz, Jose Luis;
    • Baýes‐Genís, Antonio;
    • Núñez, Julio
    Publication type:
    Article
    41

    Issue Information.

    Published in:
    European Journal of Heart Failure, 2022, v. 24, n. 10, p. i, doi. 10.1002/ejhf.2425
    Publication type:
    Article
    42

    Midazolam versus morphine in acute cardiogenic pulmonary oedema: results of a multicentre, open-label, randomized controlled trial.

    Published in:
    2022
    By:
    • Domínguez‐Rodríguez, Alberto;
    • Suero‐Mendez, Coral;
    • Burillo‐Putze, Guillermo;
    • Gil, Victor;
    • Calvo‐Rodriguez, Rafael;
    • Piñera‐Salmeron, Pascual;
    • Llorens, Pere;
    • Martín‐Sánchez, Francisco J.;
    • Abreu‐Gonzalez, Pedro;
    • Miró, Òscar;
    • Bredy, Clara Gironés;
    • Lozano, Miguel Benito;
    • Hernández, María Ángeles López;
    • Ramos, Iván Hernández;
    • Sánchez, Agustina Jurado;
    • Díaz, Aceysele Gonzalez;
    • Martín, Elena Porcel;
    • Cid, Darío Giménez;
    • Bellido, María Cabra;
    • Ruiz, Ana Pérez
    Publication type:
    journal article